Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

On This Page

All Headings will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Name, Email, Phone	Room	Group(s)/Office	ID
Asefa, Wosene wosene.asefa@nih.gov 240-276-6422	5E504	Program Support Assistant \| Chemopreventive Agent Development	546
Biswas, Kajal, Ph.D. kajal.biswas2@nih.gov 240-276-5614	5E540	Program Officer \| Chemopreventive Agent Development	540
Boring, Daniel, R.Ph., Ph.D. [C] daniel.boring@nih.gov 240-276-6422		Contractor \| Chemopreventive Agent Development	1354
Cholewa, Brian, Ph.D. brian.cholewa@nih.gov 240-276-7545	5E542	Deputy Chief \| Chemopreventive Agent Development	558
Clifford, John, Ph.D. john.clifford@nih.gov 202-235-4482	5E538	Program Officer \| Chemopreventive Agent Development	542
Gunasekharan, Vignesh, Ph.D. vignesh.gunasekharan@nih.gov 240-276-5814	5E536	Program Officer \| Chemopreventive Agent Development	573
Mohammed, Altaf, Ph.D. altaf.mohammed@nih.gov 240-276-6082	5E602	Program Officer \| Chemopreventive Agent Development	594
Nalli, Ancy, Ph.D., M.S. ancy.nalli@nih.gov 202-276-5265	5E570	Program Officer \| Chemopreventive Agent Development	2557
Sei, Shizuko, M.D. shizuko.sei@nih.gov 240-276-5005	5E452	Co-Chief \| Chemopreventive Agent Development	623
Shoemaker, Robert, Ph.D. robert.shoemaker@nih.gov 240-276-7077	5E454	Co-Chief \| Chemopreventive Agent Development Acting Chief \| Nutritional Science	624
Vlad, Anda, M.D., Ph.D. anda.vlad@nih.gov 240-276-6422	5E546	Program Officer \| Chemopreventive Agent Development	2525

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Giles, Erin	University Of Michigan At Ann Arbor United States	Obesity, body fat distribution, and breast cancer risk: is visceral fat the culprit after menopause?	5R01CA269726-02	Marjorie Perloff, M.D.
Gudas, Lorraine J	Weill Medical Coll Of Cornell Univ United States	CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention	5R01CA270248-02
Hanks, Brent Allen	Duke University United States	Role of the tumor NLRP3 inflammasome in the generation of anti-PD-1 antibody immunotherapy-associated toxicities	5R01CA251136-04	Marjorie Perloff, M.D.
Hoshida, Yujin	Ut Southwestern Medical Center United States	Reverse-engineering precision liver cancer chemoprevention	3R01CA233794-05S1	Marjorie Perloff, M.D.
Hu, Jim	Weill Medical Coll Of Cornell Univ United States	Pelvic fascia spARing radical prostatectomy TrIAL (PARTIAL)	5R01CA259173-03	Marjorie Perloff, M.D.
Huang, Ying	Western University Of Health Sciences United States	Preventing UV-induced immunosuppression and skin carcinogenesis with R-carvedilol	5R01CA269653-03
Huberty, Jennifer Lynne	University Of Texas Hlth Science Center United States	Consumer-based meditation app, Calm, for treatment of sleep disturbance in hematological cancer patients	5R01CA262041-05	Marjorie Perloff, M.D.
Infante, Rodney E	Ut Southwestern Medical Center United States	Identifying the Cellular and Molecular Targets of JAK/STAT-Driven Adipose Wasting to Reverse Cancer Cachexia	3R01CA266900-03S1	Marjorie Perloff, M.D.
Kassie, Fekadu	University Of Minnesota United States	Lung cancer prevention and treatment by targeting ALDH1 and CD44 expressing putative lung cancer stem cells	5R01CA231210-05	Marjorie Perloff, M.D.
Kassie, Fekadu	University Of Minnesota United States	Targeting tumor cell mitochondria for the prevention and treatment of lung cancer	1R01CA285608-01A1
Largaespada, David Andrew	University Of Minnesota United States	Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention	5UH3CA244687-05
Leal, Ana Sofia Mendes	Indiana University Indianapolis United States	Nrf2, immune cells and lung cancer	7R01CA226690-06	Marjorie Perloff, M.D.
Lindau, Stacy Tessler	University Of Chicago United States	Bionic Breast Project: A Neuroprosthesis to Restore Touch Sensation and Reduce Chronic Pain After Mastectomy	5R01CA281301-02	Marjorie Perloff, M.D.
Lipkin, Steven M	Weill Medical Coll Of Cornell Univ United States	CAP-IT Center for LNP RNA Immunoprevention	5U54CA272688-03	John Clifford, Ph.D.
Mcguire, Andrew	Fred Hutchinson Cancer Center United States	Rational Vaccine Design to prevent HIV-Associated Lymphoma	5R01CA285227-02